Metraipolis › archive › dc_9b3a2bcd60ef

Berberine-taxifolin co-administration attenuates inflammatory response and intestinal barrier injury via nf-κB/NLRP3 suppression in colitis — Europe PMC PMID:41646959

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41646959
DOI
10.3389/fimmu.2025.1725084
License (as archived)
solo-consultazione
Archived
2026-11-06T15:12:13.276Z
SHA-256 of the archived text
70ed076731d771890858b5076e13cdbc6aafe1c53aed582811c6c28f473950a6
Stable URL of this page
https://metraipolis.com/documento/dc_9b3a2bcd60ef

How to cite

Berberine-taxifolin co-administration attenuates inflammatory response and intestinal barrier injury via nf-κB/NLRP3 suppression in colitis — Europe PMC PMID:41646959 — Europe PMC (en), https://europepmc.org/article/MED/41646959 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9b3a2bcd60ef (Metraipolis archive dc_9b3a2bcd60ef, sha256 70ed076731d771890858b5076e13cdbc6aafe1c53aed582811c6c28f473950a6)
BibTeX
@misc{dc9b3a2bcd60ef,
  title = {Berberine-taxifolin co-administration attenuates inflammatory response and intestinal barrier injury via nf-κB/NLRP3 suppression in colitis — Europe PMC PMID:41646959},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41646959},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9b3a2bcd60ef; sha256 70ed076731d771890858b5076e13cdbc6aafe1c53aed582811c6c28f473950a6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41646959. Agents can read the archived copy with the MCP tool read_document.